Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Perspective Therapeutics, Inc. to Present Initial Results of [212Pb]VMT-α-NET Phase 1/2a Trial at NANETS Symposium Quiver Quantitative, Inc. - Sat Nov 16, 1:20AM CST

Perspective Therapeutics will present Phase 1/2a trial results for [212Pb]VMT-α-NET at the NANETS symposium on November 22, 2024.Quiver AI SummaryPerspective Therapeutics, Inc. announced details of an...

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024 GlobeNewswire - Fri Nov 15, 3:08PM CST

CATX : 7.88 (-11.66%)
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results GlobeNewswire - Tue Nov 12, 3:05PM CST

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results GlobeNewswire - Thu Oct 31, 6:00AM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November GlobeNewswire - Tue Oct 29, 6:00AM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine GlobeNewswire - Wed Oct 23, 6:00AM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey GlobeNewswire - Wed Oct 16, 6:00AM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research GlobeNewswire - Fri Oct 11, 7:30AM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research GlobeNewswire - Thu Oct 10, 4:14PM CDT

CATX : 7.88 (-11.66%)
Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day GlobeNewswire - Mon Oct 7, 6:00AM CDT

CATX : 7.88 (-11.66%)

Barchart Exclusives

Why One Analyst Just Downgraded This Investor-Favorite Energy Dividend Stock Barchart - 7 minutes ago
What’s behind this analyst’s sudden shift to a more cautious stance on Devon Energy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot